Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

23 results

Page 1 of 2

  • Chapter 18 - Management of the Neonate

  • Edited by Esther Bui, Toronto Western Hospital, P. Emanuela Voinescu, Brigham & Women's Hospital, Boston, MA
  • Book:
    Women with Epilepsy
    Published online:
    19 December 2024
    Print publication:
    02 January 2025, pp 293-305

  • Summary

    Epilepsy requiring ongoing medical treatment is the most common neurologic disorder in pregnancy [1]. Data from a number of population-based studies estimate that maternal epilepsy is present in 0.3–1% of all pregnancies [2–7], the vast majority representing women with preexisting epilepsy, and a minority (2–10%) representing women with new-onset epilepsy during pregnancy [8, 9]. The incidence of antiseizure medication (ASM) use is estimated at 0.3–0.4% of all pregnancies, which includes those who are maintained on ASMs for neuropsychiatric disorders such as bipolar and schizoaffective disorders, a practice that has become more common in the past two decades [3–5, 10, 11].

Page 1 of 2